Dendritic Cell Based Therapy for Breast Cancer Patients
|ClinicalTrials.gov Identifier: NCT00935558|
Recruitment Status : Withdrawn (no patients enrolled)
First Posted : July 9, 2009
Last Update Posted : May 31, 2012
Inge Marie Svane
Information provided by (Responsible Party):
Inge Marie Svane, Herlev Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||May 2012|
|Study Completion Date :||No date given|
Svane IM, Pedersen AE, Johansen JS, Johnsen HE, Nielsen D, Kamby C, Ottesen S, Balslev E, Gaarsdal E, Nikolajsen K, Claesson MH. Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers. Cancer Immunol Immunother. 2007 Sep;56(9):1485-99. Epub 2007 Feb 7.